Applied One Health: Nigeria National Veterinary Research Institute COVID-19 pandemic response.

IF 1.5 3区 农林科学 Q2 VETERINARY SCIENCES
Clement A Meseko, Ismaila Shittu, Olayinka O Asala, Adeyinka J Adedeji, Tinuke A Laleye, Ebere R Agusi, Dorcas A Gado, Kayode A Olawuyi, Nicodemus Mkpuma, Chinyere Chinonyerem, Bitrus Inuwa, Nneka Chima, Ruth Akintola, Patrick Nyango, Hellen Luka, Judith Bakam, Rebecca Atai, Dennis Kabantiyok, Mark Samson, ThankGod Daniel, Joshua Oyetunde, Olajide A Owolodun, David D Lazarus, Emmanuel T Obishakin, Pam D Luka, Benshak J Audu, Sunday Makama, Hussaini G Ularamu, Yiltawe S Wungak, James S Ahmed, Reuben A Ocholi, Maryam Muhammad
{"title":"Applied One Health: Nigeria National Veterinary Research Institute COVID-19 pandemic response.","authors":"Clement A Meseko, Ismaila Shittu, Olayinka O Asala, Adeyinka J Adedeji, Tinuke A Laleye, Ebere R Agusi, Dorcas A Gado, Kayode A Olawuyi, Nicodemus Mkpuma, Chinyere Chinonyerem, Bitrus Inuwa, Nneka Chima, Ruth Akintola, Patrick Nyango, Hellen Luka, Judith Bakam, Rebecca Atai, Dennis Kabantiyok, Mark Samson, ThankGod Daniel, Joshua Oyetunde, Olajide A Owolodun, David D Lazarus, Emmanuel T Obishakin, Pam D Luka, Benshak J Audu, Sunday Makama, Hussaini G Ularamu, Yiltawe S Wungak, James S Ahmed, Reuben A Ocholi, Maryam Muhammad","doi":"10.4102/ojvr.v91i2.2156","DOIUrl":null,"url":null,"abstract":"<p><p>The COVID-19 pandemic has caused the death of 7.1 million people worldwide as of 7 July 2024. In Nigeria, the first confirmed case was reported on 27 February 2020, subsequently followed by a nationwide spread of SARS-CoV-2 with morbidity and mortality reaching 267 173 and 3155, respectively, as of 7 July 2024. At the beginning of the pandemic, only a few public health laboratories in Nigeria had the capacity for SARS-CoV-2 molecular diagnosis. The National Veterinary Research Institute (NVRI), already experienced in influenza diagnosis, responded to the public health challenge for the diagnosis of COVID-19 samples from humans. The feat was possible through the collective utilisation of NVRI human and material resources, including biosafety facilities, equipment, reagents and consumables donated by international partners and collaborators. Within 6 months of the reported COVID-19 outbreak in Nigeria, over 33 000 samples were processed in NVRI facilities covering five states. Thereafter, many field and laboratory projects were jointly implemented between NVRI and collaborating sectors including the Nigerian Centre for Disease Control (NCDC) and the National Institute for Medical Research (NIMR), which brought together professionals in the health, veterinary, education and socio-sciences. In addition, One Health grants were secured to enhance surveillance for coronavirus and other zoonoses and build capacity in genomics. Bio-surveillance for coronaviruses and other emerging zoonotic pathogens at the human-animal interface was activated and continued with sample collection and analysis in the laboratory for coronaviruses, Lassa fever virus and Mpox. One Health approach has shown that inter-sectoral and multinational collaboration for diagnosis, research and development in animals, and the environment to better understand pathogen spillover events at the human-animal interface is an important global health priority and pandemic preparedness.</p>","PeriodicalId":54685,"journal":{"name":"Onderstepoort Journal of Veterinary Research","volume":"91 2","pages":"e1-e6"},"PeriodicalIF":1.5000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11447676/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onderstepoort Journal of Veterinary Research","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.4102/ojvr.v91i2.2156","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

The COVID-19 pandemic has caused the death of 7.1 million people worldwide as of 7 July 2024. In Nigeria, the first confirmed case was reported on 27 February 2020, subsequently followed by a nationwide spread of SARS-CoV-2 with morbidity and mortality reaching 267 173 and 3155, respectively, as of 7 July 2024. At the beginning of the pandemic, only a few public health laboratories in Nigeria had the capacity for SARS-CoV-2 molecular diagnosis. The National Veterinary Research Institute (NVRI), already experienced in influenza diagnosis, responded to the public health challenge for the diagnosis of COVID-19 samples from humans. The feat was possible through the collective utilisation of NVRI human and material resources, including biosafety facilities, equipment, reagents and consumables donated by international partners and collaborators. Within 6 months of the reported COVID-19 outbreak in Nigeria, over 33 000 samples were processed in NVRI facilities covering five states. Thereafter, many field and laboratory projects were jointly implemented between NVRI and collaborating sectors including the Nigerian Centre for Disease Control (NCDC) and the National Institute for Medical Research (NIMR), which brought together professionals in the health, veterinary, education and socio-sciences. In addition, One Health grants were secured to enhance surveillance for coronavirus and other zoonoses and build capacity in genomics. Bio-surveillance for coronaviruses and other emerging zoonotic pathogens at the human-animal interface was activated and continued with sample collection and analysis in the laboratory for coronaviruses, Lassa fever virus and Mpox. One Health approach has shown that inter-sectoral and multinational collaboration for diagnosis, research and development in animals, and the environment to better understand pathogen spillover events at the human-animal interface is an important global health priority and pandemic preparedness.

应用单一保健:尼日利亚国家兽医研究所 COVID-19 大流行应对措施。
截至 2024 年 7 月 7 日,COVID-19 大流行已造成全球 710 万人死亡。在尼日利亚,2020 年 2 月 27 日报告了首例确诊病例,随后,SARS-CoV-2 在全国范围内传播,截至 2024 年 7 月 7 日,发病率和死亡率分别达到 267 173 例和 3155 例。疫情开始时,尼日利亚只有少数公共卫生实验室具备 SARS-CoV-2 分子诊断能力。国家兽医研究所(NVRI)在流感诊断方面已经有了丰富的经验,它对诊断来自人类的 COVID-19 样本的公共卫生挑战做出了回应。通过集体利用国家兽医研究所的人力和物力资源,包括国际合作伙伴和协作者捐赠的生物安全设施、设备、试剂和消耗品,这一壮举才得以实现。在尼日利亚报告爆发 COVID-19 疫情后的 6 个月内,NVRI 涵盖 5 个州的设施处理了超过 33 000 份样本。此后,该研究所与尼日利亚疾病控制中心(NCDC)和国家医学研究所(NIMR)等合作部门联合实施了许多实地和实验室项目,汇集了卫生、兽医、教育和社会科学领域的专业人员。此外,还获得了 "一个健康 "赠款,用于加强对冠状病毒和其他人畜共患病的监测以及基因组学方面的能力建设。启动了冠状病毒和其他新出现的人兽共患病病原体的生物监测,并继续在实验室收集和分析冠状病毒、拉沙热病毒和 Mpox 的样本。一个健康 "方法表明,在动物和环境的诊断、研究和开发方面开展跨部门和多国合作,以更好地了解人与动物交界处的病原体外溢事件,是重要的全球卫生优先事项和大流行病防备工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
13
审稿时长
16 weeks
期刊介绍: The Onderstepoort Journal of Veterinary Research, is the official publication of the Onderstepoort Veterinary Institute. While it considers submissions from any geographic region, its focus is on Africa and the infectious and parasitic diseases and disease vectors that affect livestock and wildlife on the continent.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信